Titlebook: Stem Cell Surgery Trials in Heart Failure and Diabetes; A Concise Guide Jeffrey N. Weiss Book 2022 The Editor(s) (if applicable) and The Au

MEEK

Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patientsion of autologous bone marrow-derived mononuclear cells in addition to state-of-the-art treatment is safe and reduces all-cause mortality in patients with reduced left ventricular ejection fraction (≤45%) after successful reperfusion for acute myocardial infarction when compared with a control group

stroke

diathermy

ICMNC-HF: IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patientsinfusion of autologous bone marrow mononuclear cells is safe and effective in heart failure patients with reduced left ventricular ejection fraction (<=30%) when compared with a control group comprising of patients undergoing the best medical care.

領(lǐng)巾

杠桿支點(diǎn)

Book 2022izes the current worldwide stem cell trials for heart failure. Subsequent chapters in part two analyze the current worldwide stem cell trials in patients with Diabetes Mellitus. Both sections utilize studies that include non-expanded stem cells; each study is grouped by stem cell type and geographic

Slit-Lamp

步兵

橫條

Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patientswith reduced left ventricular ejection fraction (≤45%) after successful reperfusion for acute myocardial infarction when compared with a control group comprising of patients undergoing the best medical care.

foreign

和平